Cargando…
Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833302/ https://www.ncbi.nlm.nih.gov/pubmed/36660353 http://dx.doi.org/10.4084/MJHID.2023.011 |
_version_ | 1784868208707108864 |
---|---|
author | Sgherza, Nicola Curci, Paola Rizzi, Rita Larocca, Angela Maria Vittoria Vimercati, Luigi Tafuri, Silvio Chironna, Maria Musto, Pellegrino |
author_facet | Sgherza, Nicola Curci, Paola Rizzi, Rita Larocca, Angela Maria Vittoria Vimercati, Luigi Tafuri, Silvio Chironna, Maria Musto, Pellegrino |
author_sort | Sgherza, Nicola |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9833302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Università Cattolica del Sacro Cuore |
record_format | MEDLINE/PubMed |
spelling | pubmed-98333022023-01-18 Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) Sgherza, Nicola Curci, Paola Rizzi, Rita Larocca, Angela Maria Vittoria Vimercati, Luigi Tafuri, Silvio Chironna, Maria Musto, Pellegrino Mediterr J Hematol Infect Dis Scientific Letter Università Cattolica del Sacro Cuore 2023-01-01 /pmc/articles/PMC9833302/ /pubmed/36660353 http://dx.doi.org/10.4084/MJHID.2023.011 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Scientific Letter Sgherza, Nicola Curci, Paola Rizzi, Rita Larocca, Angela Maria Vittoria Vimercati, Luigi Tafuri, Silvio Chironna, Maria Musto, Pellegrino Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) |
title | Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) |
title_full | Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) |
title_fullStr | Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) |
title_full_unstemmed | Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) |
title_short | Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) |
title_sort | humoral immune response after anti-sars-cov-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (mgus) |
topic | Scientific Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833302/ https://www.ncbi.nlm.nih.gov/pubmed/36660353 http://dx.doi.org/10.4084/MJHID.2023.011 |
work_keys_str_mv | AT sgherzanicola humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT curcipaola humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT rizzirita humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT laroccaangelamariavittoria humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT vimercatiluigi humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT tafurisilvio humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT chironnamaria humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus AT mustopellegrino humoralimmuneresponseafterantisarscov2vaccineboosterdoseinpatientswithmonoclonalgammopathyofundeterminedsignificancemgus |